Dry Needling in Multiple Sclerosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Dry needling, Sham dry needling.
- Who it may be relevant to
- Registry conditions: Multiple Sclerosis, Spasticity. Basic parameters: 18 years — 64 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effectiveness of Dry Needling on Reducing Spasticity and Promoting Mobility and Balance in People With Multiple Sclerosis
Overview
The investigators are doing this study to see if a treatment called dry needling improves muscle spasticity (muscle tightness) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those in acupuncture, to target some muscles, like calf muscles. It differs from traditional acupuncture as it focuses on treating or managing muscle spots, aiming to reduce muscle stiffness and pain. Dry needling may offer a minimally-invasive and medication-free approach to improve muscle spasticity. The investigators hope to see if dry needling also helps enhance balance and walking abilities. This might provide potential improvements inoverall mobility and balance.
Interventions
- Device Dry needling
The dry needling technique will employ in the current proposed study follows the standard technique for needling patients with spasticity - Device Sham dry needling
In the control group, The investigators will use the methods proposed by Cushman et al. to apply sham dry needling (DN) to our participants
Primary outcome measures
- Spasticity [Time frame: 5 weeks]
Eligibility criteria
Inclusion criteria
- Age 18 to 64 years
- Clinical diagnosis of Multiple Sclerosis based on the McDonald Criteria
- Spasticity in their lower legs
- Patient Determined Disease Steps (PDDS) score of 5 or below
Exclusion criteria
- Inability to communicate effectively with study personnel
- Needle phobia
- Severe varicose veins
- Presence of an active implanted device
- Pregnancy
- Any active cancer or history within 1 year
- known or suspected infection at the site of needling or in the surrounding area
- Presence of a fixed plantarflexion contracture at the ankle
- Acute fracture of dislocation in the region (bilateral lower extremity)
- Deep vein thrombosis or peripheral vascular disease
- Thrombophlebitis, or active osteomyelitis in the region (bilateral lower extremity)
- Any medication changes, including antispastic medicines, for the past three months.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Mobility and Falls Lab — Kansas City
Identifiers
NCT: NCT06394310 · STUDY00151015